Cara Therapeutics | CARA - Ativo Circulante





Ativo Circulante Alterar Data
Acadia Pharmaceuticals USD 1.22B 128.53M 2026-06
Alterity Therapeutics Limited AUD 37.91M 15.92M 2025-12
Cara Therapeutics USD 25.33M 6.21M 2026-03
Cassava Sciences USD 87.96M 9.74M 2026-03
Chugai Pharma JPY 1.7T 164.75B 2026-06
Cipla INR 241.47B 7.71B 2026-03
Clal Biotechnology ILS 14.69M 1.95M 2023-12
Compugen USD 137.28M 10.74M 2026-03
CSL USD 11.85B 1000K 2025-12
Grifols EUR 5.96B 316.31M 2025-12
Halozyme Therapeutics USD 933.02M 70.01M 2026-06
J&J USD 59.77B 601M 2026-06
Neurocrine Biosciences USD 1.64B 798.6M 2026-06
Pacira USD 615.21M 100.25M 2026-06
Pfizer USD 41.36B 1.46B 2026-06
RedHill Biopharma USD 6.53M 6.03M 2025-12
Supernus Pharmaceuticals USD 723.5M 8.08M 2026-06
Vanda Pharmaceuticals USD 347.26M 20.23M 2025-12